Online Program Home
My Program

Abstract Details

Activity Number: 416 - Clinical Trial Design- 4
Type: Contributed
Date/Time: Tuesday, July 31, 2018 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract #329400 Presentation
Title: A Bayesian Framework for Calculating Predictive Probability of Success in Biomarker Development
Author(s): Cong Li* and Ling Wang and Ray Liu
Companies: and Takeda and Takeda Pharmaceuticals Inc
Keywords: Biomarker; predictive probability of success; precision medicine

In drug development, biomarkers can be used to help select patients that are more likely to benefit from the treatment, and developing these biomarkers has associated milestones and risks. To allow for proper go/no-go decision making of biomarker development, we developed a Bayesian framework for calculating the predictive probability of success of biomarker development. Given the data observed in the 'training' phase, the proposed method estimates the probability of observing a successful validation of the biomarker in the 'validation' phase. We consider the settings of both single-arm studies and randomized two-arm studies. In both cases, data from the training phase was used to make inferences on efficacy parameters in both biomarker+ and biomarker- populations, which were then utilized to predict the probability that pre-specified PPV and NPV criteria can be met in the 'validation' phase.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2018 program